Clinical characteristics, appropriateness of empiric antibiotic therapy, and outcome of Pseudomonas aeruginosa bacteremia across multiple community hospitals

被引:4
作者
Teelucksingh, Keith [1 ,2 ]
Shaw, Eric [3 ]
机构
[1] South Atlantic Div, HealthTrust Supply Chain, Charleston, SC 29492 USA
[2] 900 Isl Pk Dr,Suite 290, Charleston, SC 29492 USA
[3] Mem Hlth Univ Med Ctr, Mercer Univ, Sch Med, 4700 Waters Ave, Savannah, GA 31404 USA
关键词
Pseudomonas aeruginosa; Bacteremia; Community hospital; Empiric treatment; BLOOD-STREAM INFECTIONS; EFFECTIVE ANTIMICROBIAL THERAPY; DISEASES SOCIETY; CULTURE IDENTIFICATION; PRACTICE GUIDELINES; MORTALITY; MANAGEMENT; PNEUMONIA; DIAGNOSIS; ADULTS;
D O I
10.1007/s10096-021-04342-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There is relatively little contemporary information regarding clinical characteristics of patients with Pseudomonas aeruginosa bacteremia (PAB) in the community hospital setting. This was a retrospective, observational cohort study examining the clinical characteristics of patients with PAB across several community hospitals in the USA with a focus on the appropriateness of initial empirical therapy and impact on patient outcomes. Cases of PAB occurring between 2016 and 2019 were pulled from 8 community medical centers. Patients were classified as having either positive or negative outcome at hospital discharge. Several variables including receipt of active empiric therapy (AET) and the time to receiving AET were collected. Variables with a p value of < 0.05 in univariate analyses were included in a multivariable logistic regression model. Two hundred and eleven episodes of PAB were included in the analysis. AET was given to 81.5% of patients and there was no difference in regard to outcome (p = 0.62). There was no difference in the median time to AET in patients with a positive or negative outcome (p = 0.53). After controlling for other variables, age, Pitt bacteremia score >= 4, and septic shock were independently associated with a negative outcome. A high proportion of patients received timely, active antimicrobial therapy for PAB and time to AET did not have a significant impact on patient outcome.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 35 条
  • [1] Bloodstream Infections in Community Hospitals in the 21st Century: A Multicenter Cohort Study
    Anderson, Deverick J.
    Moehring, Rebekah W.
    Sloane, Richard
    Schmader, Kenneth E.
    Weber, David J.
    Fowler, Vance G., Jr.
    Smathers, Emily
    Sexton, Daniel J.
    [J]. PLOS ONE, 2014, 9 (03):
  • [2] Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study
    Babich, Tanya
    Naucler, Pontus
    Valik, John Karlsson
    Giske, Christian G.
    Benito, Natividad
    Cardona, Ruben
    Rivera, Alba
    Pulcini, Celine
    Fattah, Manal Abdel
    Haquin, Justine
    MacGowan, Alasdair
    Grier, Sally
    Chazan, Bibiana
    Yanovskay, Anna
    Ben Ami, Ronen
    Landes, Michal
    Nesher, Lior
    Zaidman-Shimshovitz, Adi
    McCarthy, Kate
    Paterson, David L.
    Tacconelli, Evelina
    Buhl, Michael
    Maurer, Susanna
    Rodriguez-Bano, Jesus
    Morales, Isabel
    Oliver, Antonio
    Ruiz de Gopegui, Enrique
    Cano, Angela
    Machuca, Isabel
    Gozalo-Marguello, Monica
    Martinez-Martinez, Luis
    Gonzalez-Barbera, Eva M.
    Gomez Alfaro, Iris
    Salavert, Miguel
    Beovic, Bojana
    Saje, Andreja
    Mueller-Premru, Manica
    Pagani, Leonardo
    Vitrat, Virginie
    Kofteridis, Diamantis
    Zacharioudaki, Maria
    Maraki, Sofia
    Weissman, Yulia
    Paul, Mical
    Dickstein, Yaakov
    Leibovici, Leonard
    Yahav, Dafna
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (02)
  • [3] Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing
    Banerjee, Ritu
    Teng, Christine B.
    Cunningham, Scott A.
    Ihde, Sherry M.
    Steckelberg, James M.
    Moriarty, James P.
    Shah, Nilay D.
    Mandrekar, Jayawant N.
    Patel, Robin
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (07) : 1071 - 1080
  • [4] Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection
    Battle, Sarah E.
    Augustine, Matthew R.
    Watson, Christopher M.
    Bookstaver, P. Brandon
    Kohn, Joseph
    Owens, William B.
    Baddour, Larry M.
    Al-Hasan, Majdi N.
    [J]. INFECTION, 2019, 47 (04) : 571 - 578
  • [5] Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis
    Battle, Sarah E.
    Bookstaver, P. Brandon
    Justo, Julie Ann
    Kohn, Joseph
    Albrecht, Helmut
    Al-Hasan, Majdi N.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (01) : 299 - 304
  • [6] Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections
    Bauer, Karri A.
    West, Jessica E.
    O'Brien, James M.
    Goff, Debra A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) : 2907 - 2912
  • [7] PSEUDOMONAS BACTEREMIA - RETROSPECTIVE ANALYSIS OF 410 EPISODES
    BODEY, GP
    JADEJA, L
    ELTING, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (09) : 1621 - 1629
  • [8] Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure
    Buehrle, Deanna J.
    Shields, Ryan K.
    Clarke, Lloyd G.
    Potoski, Brian A.
    Clancy, Cornelius J.
    Nguyen, M. Hong
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)
  • [9] Centers for Disease Control, 2020, NAT HEALTHC SAF NETW
  • [10] ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY
    CHOW, JW
    FINE, MJ
    SHLAES, DM
    QUINN, JP
    HOOPER, DC
    JOHNSON, MP
    RAMPHAL, R
    WAGENER, MM
    MIYASHIRO, DK
    YU, VL
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 585 - 590